Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Current Deferred Revenue (2022 - 2025)

OneMedNet has reported Current Deferred Revenue over the past 4 years, most recently at $389000.0 for Q4 2025.

  • Quarterly Current Deferred Revenue fell 30.66% to $389000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $389000.0 through Dec 2025, down 30.66% year-over-year, with the annual reading at $389000.0 for FY2025, 30.66% down from the prior year.
  • Current Deferred Revenue was $389000.0 for Q4 2025 at OneMedNet, down from $770000.0 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $770000.0 in Q3 2025 and troughed at $184000.0 in Q4 2022.
  • The 4-year median for Current Deferred Revenue is $456000.0 (2024), against an average of $451798.2.
  • Year-over-year, Current Deferred Revenue surged 120.87% in 2024 and then tumbled 30.66% in 2025.
  • A 4-year view of Current Deferred Revenue shows it stood at $184000.0 in 2022, then soared by 38.04% to $254000.0 in 2023, then surged by 120.87% to $561000.0 in 2024, then plummeted by 30.66% to $389000.0 in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Current Deferred Revenue are $389000.0 (Q4 2025), $770000.0 (Q3 2025), and $512000.0 (Q2 2025).